Institute of Medicine finds mitochondrial replacement therapy is ethical

In findings released February 3, an  Institute of Medicine panel has deemed mitochondrial transfer therapy ethical. This has important implications for the basic research of OHSU’s Shoukhrat Mitalipov and colleagues in the Center for Embryonic and Gene Therapy, though a Congressional ban on researching this therapy in humans remains in effect.

Update: The IOM panel’s report has garnered major media interest–for example, see more here, here, here, and here.

Bookmark and Share

Comments are closed.

About the Author

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives